Skip to main content
. 2022 Mar 23;11(2):571–595. doi: 10.1007/s40120-022-00339-7

Fig. 3.

Fig. 3

Treat-2-target algorithm of NEDA in relapsing forms of MS (adapted from Giovannoni et al. [39]). MS Multiple sclerosis, NABs neutralizing antibodies, NEDA no evidence of disease reactivation, Rx treatment